HOOKIPA Pharma Inc. (HOOK)
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
Address
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK, NY 10118
Founded
2011
Number of Employees
151
Website
http://www.hookipapharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)